Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s
Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study which evaluated the vaccine’s performance in a real-world setting.
Read Original Article: Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s »
